| Literature DB >> 21643933 |
Robert Christiaan Maat1, Magnus Hilland, Ola Drange Røksund, Thomas Halvorsen, Jan Olofsson, Hans Jørgen Aarstad, John-Helge Heimdal.
Abstract
The current follow-up study concerning the supraglottic type of exercise-induced laryngeal obstruction (EILO) was performed to reveal the natural history of supraglottic EILO and compare the symptoms, as well as the laryngeal function in conservatively versus surgically treated patients. A questionnaire-based survey was conducted 2-5 years after EILO was diagnosed by a continuous laryngoscopy exercise (CLE) test in 94 patients with a predominantly supraglottic obstruction. Seventy-one patients had been treated conservatively and 23 with laser supraglottoplasty. The questionnaire response rate was 70 and 100% in conservatively treated (CT) and surgically treated (ST) patients, respectively. A second CLE test was performed in 14 CT and 19 ST patients. A visual analogue scale on symptom severity indicated improvements in both the groups, i.e. mean values (± standard deviations) declined from 73 (20) to 53 (26) (P < 0.001) in the CT group and from 87 (26) to 25 (27) (P < 0.001) in the ST group. At follow-up, ST patients reported lower scores regarding current level of complaints, and higher ability to perform exercise, as well as to push themselves physically, all compared to CT patients (P < 0.001). CLE scores were normalized in 3 of 14 (21%) CT and 16 of 19 (84%) ST patients (Z = -3.6; P < 0.001). In conclusion, symptoms of EILO diagnosed in adolescents generally decreased during 2-5 years follow-up period but even more after the surgical treatment. Patients with supraglottic EILO may benefit from supraglottoplasty both as to laryngeal function and symptom relief.Entities:
Mesh:
Year: 2011 PMID: 21643933 PMCID: PMC3166603 DOI: 10.1007/s00405-011-1656-1
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503
Fig. 1Schematic overview chart concerning inclusion of patients and questionnaire response
Demographic data of patients included in the survey
| Treatment | Conservative ( | Surgical ( |
|
|---|---|---|---|
| Gender (male/female) | 14/36 | 9/14 | |
| Agea | 14.7 (3.7)b | 15.1 (3.8) | 0.679c |
| Follow-up time in days | 1369 (696) | 1272 (713) | 0.585 |
| CLE test sum scored | 3.4 (0.8) | 3.9 (1.0) | 0.072e |
| Supraglottic obstructionf | 2.0 (0.1) | 2.2 (0.4) | 0.005 |
| Glottic obstructionf | 0.7 (0.7) | 0.9 (0.8) | 0.365 |
aAge at time of diagnosis (first CLE test)
bData presented as mean (SD)
c P value based on independent-samples t test
dCLE score at the first CLE test (diagnosis)
e P value based on Mann–Whitney test
fAt maximal intensity
Fig. 2a Change in severity of exercise-induced laryngeal obstruction symptoms, as given by visual analogue scores between- and within the treated and untreated group (VAS at diagnosis by memory). b Athletic activity level obtained at diagnosis compared to the follow-up
Follow-up question response
| Treatment | Conservative ( | Surgical ( |
|
|---|---|---|---|
|
| |||
| I have presently no breathing difficulties during exercise | 0a | 34 | <0.001b |
| The breathing difficulties have become less | 32 | 62 | 0.020 |
| The breathing difficulties have not changed | 60 | 4 | <0.001 |
| The breathing difficulties have become worse | 8 | 0 | 0.163 |
|
| |||
| I am less active for other reasons than breathing difficulties | 24 | 39 | 0.141 |
| I am less active because of my breathing difficulties | 24 | 9 | 0.114 |
| I am as active now as I was at the time of the examination | 34 | 13 | 0.056 |
| I am more active | 16 | 39 | 0.034 |
| Missing answers | 2 | 0 | |
aFigures are percentages of group
b P value based on Chi-square test
Follow-up question response
| Treatment | Conservative ( | Surgical ( |
|
|---|---|---|---|
| What is your | 2.6 (0.7)a | 1.9 (0.8) | 0.001b |
| My breathing difficulties have been distressing | 2.5 (1.2) | 2.6 (1.3) | 0.894 |
| The difficulties have led to less social interaction | 1.5 (0.8) | 1.5 (0.9) | 0.919 |
| The difficulties have made me feel sad | 3.0 (1.2) | 2.7 (1.2) | 0.330 |
| The difficulties have kept me from achieving what I wanted | 3.1 (1.2) | 3.3 (1.1) | 0.485 |
| I have breathing difficulties when I am at rest | 1.3 (0.6) | 1.1 (0.4) | 0.178 |
| I get breathing difficulties during physical activity | 3.2 (1.1) | 2.2 (1.3) | 0.002 |
| I hear sounds from my airways when I am physical active | 2.7 (1.2) | 2.2 (1.1) | 0.105 |
| My breathing difficulties prevent me from exercising | 2.2 (1.4) | 1.5 (1.2) | 0.040 |
| I get frightened when the breathing difficulties occur | 2.0 (1.2) | 1.8 (1.4) | 0.532 |
| I tend to not push myself physically because of my symptoms | 2.7 (1.4) | 1.6 (0.9) | 0.001 |
| My symptoms continue even after stop | 2.1 (1.1) | 1.8 (1.1) | 0.173 |
| Delta VASc (%) | 17.4 (28.0) | 60.9 (25.3) | <0.001 |
| Delta current level of complaintsc | 0.4 (0.9) | 1.7 (0.9) | <0.001 |
| Delta level of athletic activityc | 1.0 (1.0) | 1.3 (1.1) | 0.257 |
aData presented as mean (SD)
b P value based on independent-samples t test
cValues from questions at follow-up subtracted from the same questions at inclusion
Scores from the continuous laryngoscopy exercise test (CLE test) at diagnosis and at follow-up in patients examined twice
| Treatment | Surgical ( | Conservative ( | ||||
|---|---|---|---|---|---|---|
| At diagnosis | At follow-up |
| At diagnosis | At follow-up |
| |
| CLE test sum score | 4.3 (1.2)a | 2.1 (0.7) | <0.001b | 4.1 (0.9) | 3.4 (1.2) | 0.027b |
| Supraglottic score | 3.0 (0.8) | 1.7 (0.6) | <0.001 | 2.8 (0.6) | 2.4 (0.9) | 0.082 |
| Glottic score | 1.3 (0.9) | 0.4 (0.5) | <0.001 | 1.3 (0.6) | 1.0 (0.6) | 0.040 |
aData presented as mean (SD)
b P value based on paired-samples t test
Fig. 3Change in continuous laryngoscopy exercise sub-scores for patients without treatment and surgically treated patients where the CLE score from the second CLE test is subtracted from the first CLE test (the vocal folds showed normal abduction at moderate effort in all the cases, therefore, this is not shown)
Fig. 4Proposed flow chart for treatment of EILO, based on clinical experience until now. Prospective studies are required to establish evidence-based treatment algorithms for patients with EILO